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ABSTRACT
The discovery of microRNAs (miRNAs) as a new
class of regulators of gene expression has triggered
an explosion of research activities, but has left many
unanswered questions about how this regulation
functions and how it is integrated with other regula-
tory mechanisms. A number of miRNAs have been
found to be present in plasma and other body fluids
of humans and mice in surprisingly high concentra-
tions. This observation was unexpected in two
respects: first, the fact that these molecules are
present at all outside the cell at significant concen-
trations and second, that these molecules appear to
be stable outside of the cell. In light of this it has
been suggested that the biological function of
miRNAs may also extend outside of the cell and
mediate cell–cell communication. We report here
that after serum deprivation several human cell
lines tested promptly export a substantial amount
of miRNAs into the culture medium and the export
process is largely energy dependent. The exported
miRNAs are found both within and outside of the
16.5 and 120K centrifugation pellets which contain
most of the known cell-derived vesicles, the
microvesicles and exosomes. We have identified
some candidate proteins involved in this system,
and one of these proteins may also play a role in
protecting extracellular miRNAs from degradation.
Our results point to a hitherto unrecognized and
uncharacterized miRNA trafficking system in mam-
malian cells that is consistent with the cell–cell
communication hypothesis.
INTRODUCTION
MicroRNAs (MiRNAs) are evolutionarily conserved,
single-stranded non-coding RNA molecules of  19–23nt
in length (1–3). It has been shown that miRNAs affect the
stability of messenger RNA (mRNA) and in some cases
inﬂuence protein translation through partial sequence
complementation with their interacting mRNA targets
(4–6). It is believed that miRNA is involved in several
important processes, such as development (7–9), viral
infection (10,11) and oncogenesis (12–14). Recently,
miRNAs have been found in extracellular space including
plasma/serum, saliva and urine in signiﬁcant concentra-
tions (15–20).
The ﬁnding of stable extracellular miRNAs in plasma
and other body ﬂuid types raises the question of the
function of such external miRNA. It suggests the possibil-
ity that they are involved in mediating cell–cell communi-
cation. This would imply that the miRNAs convey speciﬁc
information, and therefore that only some cellular
miRNAs are exported or released from cells in response
to biological stimuli. If it exists, this miRNA export mech-
anism would likely be a universal phenomenon, affecting
all cell types. The exporting cells would have to be able to
(i) identify and select speciﬁc miRNAs for export in
response to the state of the exporting cell, (ii) package
and protect the miRNAs from the hostile extracellular
environment and (iii) tag and transport these miRNA
‘packages’ to the extracellular space in a form suitable
to be taken up by targeted cells. To our knowledge no
such mechanism has yet been described or even
hypothesized.
The existence of such a communication system was
investigated using a mammalian cell culture model. The
cells were abruptly switched to a serum-free medium, and
the culture medium was collected to assess the extracellu-
lar miRNA spectrum and its dynamics in response to
stress. Most of the miRNAs we tested appeared to be
actively exported in a short pulse lasting about an hour
after serum deprivation, followed by a very modest decline
in concentration up to 48h. Using a differential centrifu-
gation approach to fractionate the medium, we found sig-
niﬁcant amounts of extracellular miRNAs that are
external to known cell-derived vesicles such as micro-
vesicles or exosomes. Exposing the cells to various
chemical inhibitors, we showed that the exportation
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found that cells release a signiﬁcant number of RNA-
binding proteins into the culture medium and one of
them, nucleophosmin 1 (NPM1), can protect miRNA
from degradation. We suggest that this protein may be
involved in the above-hypothesized system and could
play a role in the exportation, packaging and protection
of extracellular miRNAs.
MATERIALS AND METHODS
Cell culture
The HepG2, A549, T98 and BSEA2B cells were obtained
from The American Type Culture Collection (ATCC,
Manassas, VA, USA) and grown in the recommended
medium containing 10% fetal bovine serum (FBS), 100
U/ml penicillin and 100mg/ml streptomycin (Invitrogen,
Carlsbad, CA, USA) at 37 C under 5% CO2.W e
determined that this strain of HepG2 does not express
CYP2E1. The primary human pulmonary ﬁbrobast cells
were obtained from Sciencell Research Laboratories
(Sciencell, Carlsbad, CA, USA) and grown in Fibroblast
medium (Sciencell) on collagen I coated cell culture ﬂasks
(Becton Dickinson, Franklin Lakes, NJ). For serum de-
pletion experiments, the cells were plated and grown for
24h with 10% FBS containing media prior to switching to
serum-free media. Serum-free medium contained the base
medium (Invitrogen) with 100U/ml penicillin and 100mg/
ml streptomycin. For rotenone, brefeldin A and 5-N,
N-dimethyl amiloride treatments, the cell were inoculated
and grown for 24h with 10% FBS prior to exposing the
cells with different concentration of drugs for 30min.
Lactate dehydrogenase (LDH) levels were determined
with the LDH-Cytotoxicity assay kit from Abcam
(Abcam Inc., Cambridge, MA, USA) and ATP levels
were determined with the ENLITEN ATP assay system
(Promega, Madison, WI, USA) using manufacturer’s
protocol.
RNA extraction
Total RNA including miRNA was isolated using
miRNeasy kit (Qiagen, Germantown, MD, USA) with
minor modiﬁcations that have been described earlier
(21). In summary, 700ml of QIAzol reagent was added
to 300ml of culture medium samples that were spun at
1000g for 10min to remove ﬂoating cells or cell debris,
followed by addition of 140ml of chloroform. The
samples were mixed vigorously for 15s and centrifuged
at 12000g for 15min at 4 C to separate the aqueous and
organic phases. After transferring the aqueous phase to a
new collection tube, 1.5 volumes of ethanol were added
and the samples were then applied to RNeasy mini
column. Total RNA was eluted from the membrane
with 30ml of RNase-free water.
Quantitative RT–PCR
The cDNA was generated using the miScript Reverse
Transcription kit (Qiagen). In brief,  100ng of RNAs
were polyadenylated by using poly (A) polymerase and
cDNA was generated with reverse transcriptase using a
tag containing oligo-dT primers. The tag on oligo-dT
primers served as universal primer in qPCR step.
Human miScript Assay 384 set v10.1 (Qiagen) was used
for real-time PCR analysis. To reduce pipetting error,
the Matrix Hydra eDrop (Thermo Scientiﬁc, Hudson,
NH, USA) was used to mix the cDNA sample and
qPCR master reagent. The data was analyzed by SDS
Enterprise Database 2.3 (Applied Biosystems, Foster
City, CA, USA).
Microarrays
MiRNA microarrays were performed using the manu-
facturer’s (Agilent, Santa Clara, CA, USA) protocol as
described earlier (21). Hundred nanograms of total
RNA was dephosphorylated with calf intestinal alkaline
phosphate, and denatured with heat in the presence of
dimethyl sulfoxide. T4 RNA ligase added the Cyanine
3-cytidine biphosphate (pCp) to the dephosphorylated
single stranded RNA. MicroBioSpin 6 columns (Bio-
Rad, Hercules, CA, USA) were used to remove any unin-
corporated cyanine dye from the samples. The puriﬁed
labeled miRNA probes were hybridized to human
miRNA V2 oligo microarrays in a rotating hybridization
oven at 10r.p.m. for 20h at 55 C. After hybridization, the
arrays were washed in Agilent GE Wash Buffer 1 and 2
with Triton X-102. Then the array slides were dried
immediately by a nitrogen stream and scanned at 5-um
resolution by using a PerkinElmer ScanArray Express
array scanner.
Fractionation of culture medium
The cells were grown as stated earlier. The serum free
media were collected and centrifuged at 1000g for 10min
to remove cells. This supernatant (25ml) was transferred
to a new tube and spun at 16Kg for 60min, the pellet
microvesicles, were washed and resuspended
in phosphate-buffered saline (PBS, 137mM NaCl,
2.7mM KCl, 10mM Sodium Phosphate dibasic, 2mM
Potassium Phosphate monobasic at pH of 7.4). The super-
natant of the 16Kg spin was transferred to a new tube and
further centrifuged at 120Kg for 60min to pellet the
exosome particles. The exosome depleted supernatant
was then spun at 220Kg for 60min. The ﬁnal supernatant
was concentrated using Amicon Ultra Centrifugal Filter
Devices (Millipore, Billerico, MA, USA) to a ﬁnal volume
of 0.5ml. The pellets, microvesicles, exosomes, and 220Kg
pellet were resuspended in 0.5ml PBS, so that the total
volume of medium contributing to each was identical.
Mass spectrometry sample preparation and data analysis
Cells were grown as above and the serum free media
was concentrated using Amicon Ultra Centrifugal
Filter Devices (Millipore). The concentrated media was
enzymatically digested with trypsin and desalted with
C18 Ultramicrospin columns (The Nest Group,
Southborough, MA, USA). After drying in a speedvac
(Thermo Scientiﬁc, Waltham, MA, USA) the sample
was re-suspended and run on Q-TOF Ultima API Mass
Spectrometer (Waters, Bedford, MA, USA). The results
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miRNA protection assay and western blots
To test the ability of protecting miRNA from RNase
by RNA-binding protein, synthetic mir-122 RNA
(100pmol) was mixed with different proteins, NPM1
(3pmol), TGF-b (4pmol) or BSA (1.5nmol) for 30min
followed by adding RNase A (7nmol) for another
30min of incubation at 37 C. The miRNA from each con-
dition were then puriﬁed by miRNeasy kit and the
miRNA levels were determined by qPCR. Control
experiments including omitting RNAse A, protein or
miRNA were also included.
Concentrated medium and pellet samples were
separated by sodium dodecyl sulfate polyacrylamide gel
electrophoresis. The proteins were transferred to a nitro-
cellulose membrane (Bio-Rad). Human NPM1 was
detected on the western blot blocked with 5% non-fat
dry milk using an anti-NPM1 monoclonal antibody
(Sigma, St Louis, MO, USA). Near-infrared IRDye 680
labeled secondary antibodies (Li-Cor, Lincoln, NE, USA)
were used to visualize the NPM1 antibody. The membrane
was scanned using the Odyssey infrared imaging system
(Li-Cor).
RESULTS AND DISCUSSION
To investigate the miRNA mediated cell–cell communica-
tion system, we tested whether cells in culture can still
export speciﬁc miRNAs. It is not surprising that the dif-
ferent cell lines examined all release a signiﬁcant popula-
tion of extra-cellular miRNAs (Figure 1a) and they exhibit
striking differences between the cellular and extracellular
miRNA spectra (groups marked as ‘out’ or ‘in’ on the
ﬁgure for HepG2). Validation and crosschecking of
the array results was performed for HepG2 and A549 by
qPCR on selected miRNAs, as indicated in Figure 1b.
While there could be several possible explanations for
this difference between cellular and extracellular miRNA
population, including cell lysis and preferential stability
inside or outside of the cell, these results are consistent
with a speciﬁc packaging and exporting hypothesis for
extracellular miRNAs. By measuring the levels of LDH
in the medium at several time points, and examining the
cells and culture media microscopically, we ruled out sig-
niﬁcant cell lysis during the experimental period, up to
48h of culture with or without serum in the medium.
Finding no detectable evidence of signiﬁcant cell lysis
and a difference between the intracellular and extracellular
miRNA spectra, we concluded that the external miRNAs
are most likely exported from intact cells by speciﬁc
cellular mechanisms.
The elimination of serum from the culture medium
provides a strong biological stimulus to cultured cells.
When so stimulated, cells must alter their internal states
signiﬁcantly, leading to cell cycle arrest, and in some cases
cell death, during extended periods of serum depletion
(22–24). We hypothesized that cells could respond to
this change of state, in part, by exporting miRNAs
immediately after deprivation of serum. To test this, we
carefully characterized the miRNA spectra of two differ-
ent well-established cell lines, A549 and HepG2, which
were derived from different sources. HepG2 is from
human hepatocellular carcinoma (25), and A549 is from
lung epithelial carcinoma (26). The absence of bovine
serum, and the miRNAs it contains, is a distinct advan-
tage of using serum depletion to study extracellular
miRNA as it removes a potential source of interference.
There are 499 and 578 observable miRNA species in A549
cells and HepG2 cells, respectively. Among these, there are
476 miRNAs in common between the two cell lines. Fewer
than 5% of the miRNAs observed in A549 cells are not
observed in HepG2, and <18% of the miRNAs observed
in HepG2 are not observed in A549. In the culture media,
the percentages are similar (2% of the miRNAs observed
from A549 are not observed in HepG2, and 15% of the
miRNAs observed from HepG2 are not observed in
A549). Based on the global miRNA proﬁling results, we
selected a set of 30 miRNAs that showed good signals and
consistent measurement proﬁles using qPCR to study in
more detail.
In order to track the cellular responses carefully, we
carried out a time series of measurements from just
before serum deprivation (SD) to 48h after SD. This
revealed some dramatic differences in the proﬁle of
external miRNAs, not only among speciﬁc species, but
also some differences between cell lines. If we compare
the changes in levels of certain miRNAs inside and
outside of the cells, before and after serum deprivation,
the rate of export for most of the miRNAs examined in-
creases dramatically during the ﬁrst 2h after SD and
declines thereafter (Figure 2).
The extracellular miRNAs derived from cultured
cells are stable
One observation from these data was that some miRNAs
exhibited a modest decline in concentration in the medium
after increasing strongly in the ﬁrst few hours (Figure 2).
To determine whether these miRNAs were speciﬁcally
being degraded in the serum-free culture medium, we
carried out extensive time course measurements on the
decay of miRNAs in media from which the cells were
removed. The data clearly show that different miRNAs
decay at different rates (Figure 3a). The decay of
miRNAs in the medium over many hours is readily de-
tectable, but not severe for most miRNA species. The rate
of decay can be measured by
miðtÞ¼mið0Þ2 tri
where mi(t) is the level of miRNA ‘i’ at time ‘t’ and ri is
the decay rate for miRNA ‘i’. The overall decay rate
doesn’t appear to be >0.02/h (Supplemental Figure S1a).
Is the exportation of miRNA immediately after serum
deprivation from a pre-synthesized miRNA pool?
The time series data, taken together with the miRNA
decay measurements, enables us to estimate the quantita-
tive kinetics of the export of miRNA from cells after SD.
Since the levels rise rapidly for approximately the ﬁrst 2h
7250 Nucleic Acids Research, 2010,Vol.38, No. 20after SD and then remain roughly constant or decay
somewhat, we conclude that for these miRNAs there is
a strong pulse of miRNA exportation that rapidly
subsides, accompanied by the steady, but relatively slow,
decay of the miRNA outside the cell. Kinetic modeling
shows that most of our miRNA export data is consistent
with the scheme illustrated in Figure 3b. This kinetic
proﬁle, with a rapid rise in initial export rate after SD,
raises the question of whether or not the miRNA exported
is pre-synthesized and prepackaged.
To further investigate the early response from cells after
SD, we measured the intracellular levels as well as the
extracellular exported miRNA levels in the medium with
a large set of miRNAs from both cell lines. We illustrate
our general observations with some representative
miRNAs in Figure 3c: an initial drop in cellular miRNA
levels occurs simultaneously with a strong increase in
miRNA levels in serum free culture media. The qPCR
data shown here also indicates a recovery of intracellular
miRNA levels after a few hours (2–6h). This experimental
A549
HepG2
T98
BEAS2B
HPF
A549
HepG2
T98
BEAS2B
HPF
Extracellular Intracellular
OUT
IN
OUT
IN
210.0 44.0 0.0
OUT
miR-891b
miR-629*
miR-296-3p
miR-652
miR-137
miR-151-5p
miR-190
miR-553
miR-10b
miR-520d-5p
miR-382
A549 HepG2
20.00
15.00
10.00
5.00
0.00
5.00
10.00
15.00
20.00
Extracellular
Intracellular
R
e
l
a
t
i
v
e
 
r
a
t
i
o
 
o
f
 
m
i
R
N
A
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
(
D
C
t
)
(a)
(b)
Figure 1. Differential miRNA spectra between cultured cells and the medium. (a) Intra- and extracellular miRNA spectra for six different cell lines
in culture as measured by miRNA arrays. The cell lines are as indicated (T98 is derived from human glioblastoma multiforma, BEAS2B is derived
from lung bronchial epithelium and HPF are primary pulmonary ﬁbroblast cells isolated from human lung tissue). Heat maps represent the levels of
miRNA for the cell lines as indicated (red highest, green lowest). The brackets indicating ‘in’ or ‘out’ mark groups of miRNAs that show striking
differences between the intra (‘in’) and extra (‘out’) cellular concentrations speciﬁcally for HepG2 cells. (b) qPCR measurements of selected miRNAs
shown in 1a that illustrate different proﬁles for HepG2 (red) and A549 (blue). The histogram shows the external versus internal levels of selected
miRNAs. The extracellular levels are indicated above, the intracellular below.
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in Figure 3b. This data also allows us to obtain an
expanded view of the behavior of the dynamical levels of
miRNAs during the ﬁrst few hours after SD, inside and
outside of the cell, which illustrates the precise behavior
expected from the kinetic model we propose
(Supplemental Figure S1b). In addition, it seems that the
levels of intracellular miRNA overshoot then tend to relax
back to their original levels (Figure 3c). Even though we
could not deﬁnitively rule out the possibility that the rapid
changes in intra- and extracellular miRNA spectra we
observed are due to some cell lysis, the data strongly
suggests that most of the exported miRNAs are initially
from a pre-synthesized pool since the substantial export-
ation of miRNA in the ﬁrst hour is unlikely to come from
newly transcribed and processed miRNA. The initial re-
duction in intracellular levels is consistent with this view.
This observation raises an intriguing possibility of the ex-
istence of speciﬁc cellular compartment(s) to store prepro-
cessed and prepackaged miRNA. This hypothesis will be
carefully investigated in the future.
Signiﬁcant fraction of extracellular miRNAs resides
outside of previously described vesicles
The observations of miRNA outside of cells have focused
on known cell-derived vesicles, like microvesicles and
exosomes (17–19). In the serum deprivation system used
here, we were able to examine the question of how the
exported miRNA are contained or packaged in more
detail. The absence of interfering bovine miRNAs,
proteins, and other bovine serum derived biological
products in the serum-free medium enables quantita-
tive measurements that are more accurate. Using
well-developed differential-centrifugation-based methods
for microvesicle and exosome isolation (27,28), we
fractionated the media isolated from the cultures 2h
after SD (the time point which has the highest level of
extracellular miRNA based on our kinetic study, Figure
3), into four fractions (Figure 4a). The microvesicle
(16.5K pellet), exosome (120K pellet), ‘hard spin’ pellet
(this is the pellet of a ﬁnal 220 Kg spin for 1h), and super-
natant fractions were then assayed for the presence of the
miRNA species. The results of these measurements (with
three biological replicates—repeated experiments) were
surprising in several respects (Figure 4b and c). First,
counter to the expectation that miRNAs are conﬁned to
previously described cell-derived vesicles; signiﬁcant con-
centrations of miRNAs are in the ﬁnal supernatant
fraction. The second surprise is that many, but not all,
of the miRNAs are also found both in the vesicles and
the ﬁnal supernatant. The patterns of distribution showed
a strong diversity of proﬁles, falling into three to four
distinct patterns (Figure 4b for A549 and 4c for
HepG2). There are several miRNAs that are found in
almost equal proportions in all four fractions, while
several others are almost completely absent from all but
the ﬁnal supernatant fraction. This observation strongly
counters the idea that the presence of miRNA in the ﬁnal
supernatant is due to disruption of cell-derived vesicles
during fractionation procedures. The data also suggest
that many of the vesicles remain intact, as evidenced by
the high levels of some miRNAs seen in this fraction.
Therefore, the absence of some of the miRNAs, present
in the supernatant, in the vesicle fraction cannot be
explained simply by ruptured vesicles during sample pro-
cessing. Thus, while the measurements from all of these
fractions demonstrate some experimental noise, it is clear
that the dramatic quantitative differences represent real
Figure 2. Time course of levels of miRNA exported into the medium. Samples were taken at various indicated time points after serum deprivation.
The serum free medium contains no proteins or miRNAs. Most of the miRNA measured shown very similar behavior. The levels of 16 miRNAs
measured by quantitative PCR from A549 (left frame) and HepG2 (right frame). The points are the means of three biological replicates. All vertical
axes, the levels of miRNAs, are in Ct.
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These observations of miRNA distribution demonstrate
that the miRNA export system in the cells must
somehow be able to target speciﬁc miRNAs to speciﬁc
extracellular structures, but does not exclusively channel
speciﬁc miRNAs to a given fraction. There are, however,
some miRNAs that are found in the supernatant almost to
the exclusion of all other fractions (miR-219 in A549
culture medium, Figure 4b, for example). Another signiﬁ-
cant observation from this data is that even though we
showed that the two cell lines studied here export a
similar spectrum of miRNAs (Figure 1b) the distributions
of miRNAs from the two cell lines demonstrate clear dif-
ferences, as shown in Figure 4b and c. For example,
miR-145 is present at very low levels in HepG2 derived
microvesicles (Figure 4c), while the same miRNA is
present at signiﬁcant levels in both A549 derived
microvesicles and exosomes (Figure 4b). On the other
hand, there are some miRNAs, notably those that are
almost uniformly distributed among the fractions, with
the same distribution no matter which cell-line is the
source. These observations certainly indicate the degree
of complexity of this export system that will bear further
investigation.
Intracellular ATP levels affect the exportation of miRNA
To further investigate the miRNA export process, we
treated the HepG2 cells with different concentration of
rotenone, a respiratory chain inhibitor, to reduce the
cellular ATP level (29), brefeldin A (BFA), an inhibitor
of protein secretion through the interference with the
Golgi apparatus (30), and 5-N, N-dimethyl amiloride
(DMA), an inhibitor of exosome secretion through the
inhibition of H
+/Na
+ and Na
+/Ca
2+ exchangers (31), for
30min prior to SD. As expected, the cellular ATP level
showed a signiﬁcant decrease in rotenone treated cells
while the LDH levels in media showed no signiﬁcant
changes in all three treatments. We examined the levels
of select miRNAs with qPCR in both cells and culture
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Figure 3. Decay of miRNAs in the medium. The cells in culture were serum deprived for 2h, then the medium was removed and incubated under the
same conditions for varying periods of time. Speciﬁc miRNA levels were measured (three biological replicates) with quantitative PCR on each
sample. (a) The time course measurements of four selected miRNAs with standard derivations showing diverse proﬁles. (b) Model kinetics for the
export response of the majority of the miRNAs considered here, showing the rate of export as a function of time (in red) and the accumulated level
of extracellular miRNA as a function of time (in blue). (c) the intracellular response in HepG2 cells of three selected miRNAs.
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showed no signiﬁcant changes in all the treatments.
However, the levels of most of the extracellular miRNAs
examined displayed a dose dependent decrease with
rotenone treatment only (Supplemental Figure S2). This
ﬁnding suggests that: (i) most of the miRNA exporting
process is an energy dependent, active transport process,
and (ii) during the time frame examined, the export of
miRNA is not affected in any signiﬁcant way either by
BFA, independent of the Golgi apparatus, and DMA,
an inhibitor of exosome formation. It is interesting to
note that the extracellular levels of the mir-671-3P and
mir-943 are not affected by a decrease in cellular ATP
level, suggesting that the export pathway is complex and
probably involves multiple branches.
A number of RNA-binding proteins were released into
the medium by the cells
To examine the protein content of the exported miRNA
complexes, we collected and concentrated the primary
human ﬁbroblast medium 2h after SD. The proteins
were digested with trypsin and then proﬁled by mass
spectrometry. A total of 197 proteins that are represented
by more than one peptide were identiﬁed. Of these, 12
were known RNA-binding proteins (Table 1). Besides
several ribosomal proteins, it is notable that there was
a substantial level of a known nucleolar RNA-binding
protein, nucleophosmin 1 (NPM1), in the medium.
Nucleophosmin 1 is implicated in the nuclear export of
the ribosome (32,33). There was also a signiﬁcant
amount of nucleolin, a known NPM1 interacting
protein (32,34), in the medium. Since NPM1 is known
to be located primarily in the nucleolus and involved
ribosomal RNA processing, it is surprising to observe
it in signiﬁcant levels outside the cell. Using an
antibody to nucleophosmin 1, we identiﬁed the
presence of NPM1 protein in the culture media from
other cell lines.
Nucleophosmin binds miRNA and may play a role
in protecting miRNA from degradation
The vast majority of the NPM1 protein is present in
the supernatant fraction (as deﬁned in Figure 4a), and is
undetectable by western blot in either vesicle fraction
(Figure 5a). The distribution of the NPM1 protein paral-
lels the distribution of miRNAs—by far the largest con-
centration is found in the supernatant (Figure 5b). The
presence of a RNA-binding protein in this fraction,
where most of the miRNAs are found, suggests this
protein may bind miRNAs. We carried out a number of
experiments, including gel shifts and immunopreci-
pitations that conﬁrm the binding of nucleophosmin to
miRNAs.
To see whether NPM1 is involved in the unexpected
stability of the extracellular miRNA, we tested its ability
to protect miRNA from RNAse. The NPM1 protein was
incubated with synthetic miR-122 RNA prior to RNaseA
challenge. The RNA was then isolated and assessed by
qPCR. The result showed that NPM1 alone can fully
protect this miRNA from RNaseA digestion (Figure 5c).
It has been suggested that NPM1 may be involved in
shuttling RNAs and ribosomal proteins to the cytosol
(32,33,35), and in a recent report, the NPM1 protein
also been found outside the cell (36). This shuttling mech-
anism may be relevant to a possible role in miRNA
export. Our ﬁndings collectively are highly suggestive
Figure 4. miRNA levels in fractionated serum-free culture medium for A549 and HepG2. The medium, 2h after serum deprivation, was fractionated
by differential centrifugation into four fractions, microvesicles (size range: 100–1000nm), exosomes (size range: 30–100nm), one higher g spin pellet
(220K for 1h), and the remaining supernatant. The ﬁnal supernant were concentrated to a ﬁnal volume of 0.5ml and 200ml of the concentrated
media were used for miRNA analysis. Pellets were also resuspended in 0.5ml of PBS and 200ml of the solution were used for miRNA isolation. (a)
Experimental design for fractionation of medium. The levels of miRNA distribution from A549 (b) and HepG2 (c) were grouped into distinct
distribution proﬁles.
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7256 Nucleic Acids Research, 2010,Vol.38, No. 20that the nucleophosmin 1 is involved both in some part of
the miRNA exporting process and in protecting the
external miRNAs outside the cell.
To see if NPM1 is speciﬁc in its protective effect on
miRNAs, we tested a number of other RNA-binding
proteins for their protective effect under the same condi-
tions. These included nucleolin (NCL), nucleophosmin 2
(NPM2), nucleophosmin 3 (NPM3), eukaryotic transla-
tion initiation factor 2C (EIF2c2), Musashi homolog 1
(MSI1), and ELAVL protein family 3 (ELAVL3), none
of which had any signiﬁcant protective effect on our syn-
thetic miRNA, miR-122. However, we could not rule out
the possibility of a sequence preference on these
RNA-binding proteins. More synthetic miRNA are
needed to answer the question of whether other
RNA-binding proteins can also bind and protect miRNA.
Cells may have an array of miRNA packaging and
transportation systems
We have demonstrated that miRNAs are actively exported
from cells. This export process appears to be a short pulse
Figure 5. Protein exported upon serum deprivation. (a) NPM1 protein is observed in western analysis of the concentrated medium from HepG2
cells. This protein is exported into the medium, but is not found in any fraction except the supernatant (as deﬁned in legend to Figure 4) as shown by
westerns on the fractions. (b) The relative concentrations of all miRNAs measured in this work were averaged for each fraction to obtain a relative
miRNA levels in each fraction. These averages for HepG2 cells are shown in the histogram using a scale of log to base 2. (c) NPM1 protein protects
miRNA from RNase degradation. Synthetic mir-122 RNA (100pmol) was mixed with different proteins, NPM1 (black bars, 3pmol), TGF-b (gray
bars, 4pmol) or BSA (open bars, 1.5nmol) for 30min followed by adding RNase A (7nmol) for another 30min of incubation at 37 C. The miRNA
levels were determined by qPCR. Control experiments: omitting RNase A, protein, or miRNA were also included, as indicated on top of the graph.
The scale is Ct of relative mir-122 levels.
Table 1. List of all of the known RNA-binding proteins which we
observed with two or more peptide fragments in the medium
(2h after SD)
Gene symbol Number of
peptides
observed
Gene name
HNRNPA2B1 2 Heterogeneous nuclear
ribonucleoprotein a2/b1
HNRPAB 3 Heterogeneous nuclear
ribonucleoprotein a/b
ILF2 2 Interleukin enhancer binding
factor 2, 45kda
NCL 7 Nucleolin
NPM1 4 Nucleophosmin (nucleolar
phosphoprotein b23, numatrin)
RPL10A 2 Ribosomal protein l10a
RPL5 2 Ribosomal protein l5
RPLP1 6 Ribosomal protein, large, p1
RPS12 2 Ribosomal protein s12
RPS19 2 Ribosomal protein s19
SNRPG 2 Small nuclear ribonucleoprotein
polypeptide g
TROVE2 2 Trove domain family, member 2
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dynamic nature of this miRNA export system has not
been reported before, to our knowledge, and strongly
suggests both the existence of a complex response system
involving miRNA transportation in the cell and the
possible involvement of miRNA in cell–cell communica-
tion. Our results from differential centrifugation and
chemical inhibitor experiments also suggest that extracel-
lular vesicle-associated miRNAs represent only a part of
the extracellular miRNA distribution, at least for our cell
culture conditions. A signiﬁcant fraction of extracellular
miRNA is, in fact, not within the known cell-derived
vesicles. It is yet unclear how they are packaged outside
these vesicles. This leads us to speculate that there may be
at least two pathways for the packaging and export of
miRNAs, exosome/microvesicle mediated and ‘other
particle’ mediated processes. We were surprised to ﬁnd a
number of reportedly intracellular proteins in the culture
media shortly after serum depletion. At least one of these
associated RNA-binding proteins, NPM1, may play a role
in the packaging, and perhaps the export, of extracellular
miRNAs. Its role in miRNA packaging/exporting is cur-
rently being investigated.
The hypothesis of miRNA-dependent cell–cell commu-
nication based on the export of miRNA seems to be the
most satisfying explanation for the existence of extracel-
lular miRNA. There has been circumstantial evidence in
favor of this interpretation, but we provide here direct
evidence that demonstrates the export system in action
in response to serum deprivation, characterizes some of
properties of extracellular miRNA packaging, and
supports the miRNA mediated cell–cell communication
hypothesis. Our biological observations indicate an im-
portant role for miRNAs, and enable future investigations
of this potential communication system, unknown until
now.
There are important pieces of the puzzle still missing.
We have no direct evidence yet that miRNA containing
complexes are taken up by other cells, although vesicles
containing miRNA are reported to be taken up by cells
(17). We expect that miRNA outside of vesicles, com-
plexed with proteins, could be targeted to speciﬁc cell
surface receptors, and are currently investigating this im-
portant hypothesis. Our results raise signiﬁcant questions
about miRNA-mediated cell-to-cell communication, and
enable the characterization of such a system. The elucida-
tion of a novel and perhaps extensive, biological informa-
tion transduction system between cells will certainly be of
the utmost importance in understanding many biological
processes in mammalian systems including development,
stress response, and tissue renewal.
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